Target intelligence / Profile preview

Taura syndrome virus polyprotein (TSV polyprotein)

Target
TSV polyprotein
Molecular classification
Viral protein, RNA-dependent RNA polymerase, Capsid protein, Enzyme, Cysteine protease
01

Overview

Taura syndrome virus (TSV) is a major pathogen belonging to the family Dicistroviridae, primarily impacting the Pacific white shrimp (Penaeus vannamei) (Source: OIE, 2019). The TSV genome consists of a single-stranded, positive-sense RNA that encodes two large polyproteins: ORF1, which produces non-structural proteins like RNA-dependent RNA polymerase (RdRp), helicase, and protease, and ORF2, which produces structural capsid proteins VP1, VP2, and VP3 (Source: UniProt, P89873). These proteins are essential for the viral life cycle, including genome replication and the assembly of icosahedral virions that infect the cuticular epithelium of the host (Source: ICTV). In aquaculture, these proteins are targeted by experimental RNA interference (RNAi) therapies and DNA vaccines to induce protective immunity or silence viral gene expression (Source: PubMed, PMID: 15652311). Understanding the structure and function of these proteins is critical for developing diagnostic tools and biosecurity measures to control the spread of Taura syndrome, which can cause up to 95% mortality in affected shrimp populations.

Other names
TSV capsid proteinTSV VP1TSV VP2TSV VP3Taura syndrome virus non-structural proteinTSV ORF1 polyproteinTSV ORF2 polyprotein
02

Mechanism of action

RNA interference (RNAi) mediated gene silencing of viral mRNA to inhibit translation and replication, and antibody-mediated neutralization of structural capsid proteins to prevent viral entry into host cells (Source: PubMed, PMID: 15652311).

03

Biological functions

Viral genome replicationViral assemblyHost cell attachmentProteolysisRNA-directed DNA polymerase activity
04

Disease associations

InfectionTaura syndrome
05

Safety considerations

Viral mutation leading to sequence escape from RNAi treatmentsEnvironmental persistence of nucleic acid-based therapies in aquaculture systemsPotential off-target effects in the host shrimp genome
06

Interacting drugs

dsRNA (VP2-specific)

3 more in the full profile.

07

Biomarkers

TSV genomic RNA (RT-PCR)VP2 capsid protein (ELISA)Viral inclusion bodies (Histopathology)

Beyond the preview

Go deeper on Taura syndrome virus polyprotein (TSV polyprotein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taura syndrome virus polyprotein (TSV polyprotein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call